Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort

Matthew D Allard, Ramesh Saeedi, Masoud Yousefi

  • 1Healthy Heart Program Prevention Clinic, St Paul's Hospital, Vancouver, University of British Columbia, Vancouver, Canada. jifr@mail.ubc.ca.

Insights

Familial hypercholesterolemia (FH) patients show varied cardiovascular disease (CVD) risk. Key factors include sex, diabetes, high cholesterol (HDL-C), and lipoprotein (a) (Lp(a)), with differing impacts between men and women.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Familial hypercholesterolemia (FH) is an autosomal dominant disorder causing high cholesterol and premature cardiovascular disease (CVD).
  • Significant variability exists in CVD occurrence among FH patients.
  • Identifying risk factors for this variability is crucial for patient management.

Purpose of the Study:

  • To determine specific risk factors contributing to the variability of cardiovascular disease (CVD) events in patients with Familial hypercholesterolemia (FH).

Main Methods:

  • Retrospective analysis of a large, multiethnic cohort of definite FH patients.
  • Utilized Cox proportional hazard regression to assess risk factor associations with hard cardiovascular outcomes.

Main Results:

  • Identified 409 definite FH patients; 27% had CVD.
  • Significant independent risk factors for CVD included male sex, family history of premature CVD, diabetes mellitus, low high-density lipoprotein cholesterol (HDL-C), and high lipoprotein (a) (Lp(a)).
  • Risk factor impact differed by sex: family history and low HDL-C in men; smoking and high Lp(a) in women. Diabetes was significant for both.

Conclusions:

  • Cardiovascular disease (CVD) risk factors in Familial hypercholesterolemia (FH) exhibit sex-specific influences.
  • Family history and low HDL-C are key in men; smoking and high Lp(a) are key in women.
  • Diabetes mellitus is a significant CVD risk factor for both sexes in FH patients.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K